en
Scientific article
English

The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries

Published inRheumatology, vol. 60, no. 2, p. 820-828
Publication date2021
Abstract

RF and ACPA are used as diagnostic tools and their presence has been associated with clinical response to some biologic DMARDs (bDMARDs) in RA. This study compared the impact of seropositivity on drug discontinuation and effectiveness of bDMARDs in patients with RA, using head-to-head comparisons in a real-world setting.

Keywords
  • ACPA
  • PANABA
  • TOCERRA
  • Anti-citrullinated protein antibodies
  • Drug retention
  • Rheumatoid arthritis
  • Rheumatoid factor
  • Seropositivity
Citation (ISO format)
COURVOISIER, Delphine et al. The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries. In: Rheumatology, 2021, vol. 60, n° 2, p. 820–828. doi: 10.1093/rheumatology/keaa393
Main files (1)
Article (Published version)
accessLevelRestricted
Secondary files (1)
Identifiers
ISSN of the journal1462-0324
176views
0downloads

Technical informations

Creation03/23/2021 2:47:00 PM
First validation03/23/2021 2:47:00 PM
Update time03/16/2023 12:48:15 AM
Status update03/16/2023 12:48:13 AM
Last indexation05/06/2024 7:46:12 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack